Ignite Creation Date:
2024-05-05 @ 5:29 PM
Last Modification Date:
2024-10-26 @ 9:32 AM
Study NCT ID:
NCT00462943
Status:
COMPLETED
Last Update Posted:
2021-12-28
First Post:
2007-04-17
Brief Title:
Open Label Study of Subcutaneous Homoharringtonine Omacetaxine Mepesuccinate in Patients With Advanced CML
Sponsor:
Teva Branded Pharmaceutical Products RD Inc
Organization:
Teva Branded Pharmaceutical Products RD Inc
Organization Data
Organization:
Teva Branded Pharmaceutical Products RD Inc
Class:
INDUSTRY
Study ID:
CGX-635-CML-203
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Teva Branded Pharmaceutical Products RD Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| ChemGenex Pharmaceuticals | INDUSTRY |
| Cephalon | INDUSTRY |